Neurocrine Biosciences Net Profit Margin 2010-2024 | NBIX

Current and historical net profit margin for Neurocrine Biosciences (NBIX) from 2010 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue. Neurocrine Biosciences net profit margin for the three months ending December 31, 2024 was .
Neurocrine Biosciences Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2024-12-31 $2.36B $0.34B 14.48%
2024-09-30 $2.24B $0.39B 17.22%
2024-06-30 $2.12B $0.34B 16.00%
2024-03-31 $1.98B $0.37B 18.67%
2023-12-31 $1.89B $0.25B 13.25%
2023-09-30 $1.78B $0.19B 10.71%
2023-06-30 $1.67B $0.18B 10.58%
2023-03-31 $1.60B $0.06B 4.01%
2022-12-31 $1.49B $0.16B 10.41%
2022-09-30 $1.39B $0.06B 4.25%
2022-06-30 $1.30B $0.01B 1.00%
2022-03-31 $1.21B $0.07B 5.96%
2021-12-31 $1.13B $0.09B 7.94%
2021-09-30 $1.07B $0.45B 41.59%
2021-06-30 $1.03B $0.36B 35.24%
2021-03-31 $1.05B $0.40B 38.43%
2020-12-31 $1.05B $0.41B 38.91%
2020-09-30 $1.04B $0.09B 8.93%
2020-06-30 $1.01B $0.21B 20.40%
2020-03-31 $0.89B $0.18B 19.84%
2019-12-31 $0.79B $0.04B 4.70%
2019-09-30 $0.68B $0.02B 3.11%
2019-06-30 $0.61B $0.02B 2.98%
2019-03-31 $0.52B $-0.04B -7.53%
2018-12-31 $0.45B $0.02B 4.66%
2018-09-30 $0.42B $0.01B 2.41%
2018-06-30 $0.32B $-0.05B -16.05%
2018-03-31 $0.23B $-0.11B -45.49%
2013-12-31 $0.00B $-0.05B -1150.00%
2013-09-30 $0.03B $-0.03B -104.00%
2013-06-30 $0.03B $-0.02B -54.55%
2013-03-31 $0.04B $-0.01B -16.28%
2012-12-31 $0.05B $0.00B 7.55%
2012-09-30 $0.04B $0.00B -9.52%
2012-06-30 $0.08B $0.03B 40.00%
2012-03-31 $0.08B $0.03B 43.42%
2011-12-31 $0.08B $0.04B 47.44%
2011-09-30 $0.08B $0.04B 46.91%
2011-06-30 $0.05B $0.01B 18.87%
2011-03-31 $0.05B $0.00B 6.52%
2010-12-31 $0.03B $-0.01B -26.47%
2010-09-30 $0.02B $-0.02B -90.48%
2010-06-30 $0.01B $-0.03B -375.00%
2010-03-31 $0.00B $-0.04B -1000.00%
2009-12-31 $0.00B $-0.05B -1275.00%
Sector Industry Market Cap Revenue
Medical MED-DRUGS $10.546B $2.355B
Neurocrine Biosciences is a neuroscience-based company focused on the discovery and development of novel therapeutics for neuropsychiatric, neuroinflammatory and neurodegenerative diseases and disorders. The company's neuroscience, endocrine and immunology disciplines provide a unique biological understanding of the molecular interaction between central nervous, immune and endocrine systems for the development of therapeutic interventions for anxiety, depression, insomnia, stroke, malignant brain tumors, multiple sclerosis, obesity and diabetes.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) JP $95.374B 35.78
Zoetis (ZTS) US $69.448B 26.29
Daiichi Sankyo, - (DSNKY) JP $48.414B 24.63
Takeda Pharmaceutical (TAK) JP $47.824B 10.59
Sandoz Group AG (SDZNY) CH $18.977B 0.00
Summit Therapeutics (SMMT) US $18.321B 0.00
Merck (MKKGY) DE $17.848B 14.77
Shionogi (SGIOY) JP $14.096B 14.12
United Therapeutics (UTHR) US $13.255B 11.73
IPSEN (IPSEY) FR $9.907B 0.00
Orion OYJ (ORINY) FI $9.027B 24.41
Corcept Therapeutics (CORT) US $7.580B 57.65
Madrigal Pharmaceuticals (MDGL) US $7.276B 0.00
Stevanato Group S.p.A (STVN) IT $6.281B 39.88
Ono Pharmaceutical (OPHLF) JP $5.988B 12.26
Hikma Pharmaceuticals Plc (HKMPF) GB $5.813B 0.00
Ionis Pharmaceuticals (IONS) US $5.047B 0.00
Grifols, S.A (GRFS) ES $4.827B 0.00
Soleno Therapeutics (SLNO) US $3.744B 0.00
Crinetics Pharmaceuticals (CRNX) US $3.138B 0.00
Catalyst Pharmaceuticals (CPRX) US $2.960B 12.02
AMNEAL PHARMACEUTICALS, INC (AMRX) US $2.399B 14.89
Hypermarcas (HYPMY) BR $2.350B 15.46
Recursion Pharmaceuticals (RXRX) US $2.211B 0.00
NewAmsterdam Pharma (NAMS) NL $2.200B 0.00
BioCryst Pharmaceuticals (BCRX) US $1.822B 0.00
Centessa Pharmaceuticals (CNTA) GB $1.798B 0.00
Indivior (INDV) US $1.593B 6.75
Guardian Pharmacy Services (GRDN) US $1.568B 0.00
Evotec AG (EVO) DE $1.502B 0.00
ARS Pharmaceuticals (SPRY) US $1.391B 177.00
Dyne Therapeutics (DYN) US $1.362B 0.00
Ocular Therapeutix (OCUL) US $1.359B 0.00
Ardelyx (ARDX) US $1.304B 0.00
Aurinia Pharmaceuticals Inc (AUPH) CA $1.121B 45.56
Enliven Therapeutics (ELVN) US $0.974B 0.00
Harrow (HROW) US $0.917B 0.00
Collegium Pharmaceutical (COLL) US $0.869B 4.62
Avadel Pharmaceuticals (AVDL) IE $0.832B 0.00
Xencor (XNCR) US $0.773B 0.00
Cronos Group (CRON) CA $0.721B 0.00
AleAnna (ANNA) US $0.718B 0.00
Xeris Biopharma Holdings (XERS) US $0.701B 0.00
KalVista Pharmaceuticals (KALV) US $0.676B 0.00
Organogenesis (ORGO) US $0.629B 0.00
Akebia Therapeutics (AKBA) US $0.626B 0.00
Bioventus (BVS) US $0.595B 15.45
Savara (SVRA) US $0.563B 0.00
Relay Therapeutics (RLAY) US $0.561B 0.00
USANA Health Sciences (USNA) US $0.529B 11.35
Regulus Therapeutics (RGLS) US $0.520B 0.00
Theravance Biopharma (TBPH) KY $0.520B 0.00
Verve Therapeutics (VERV) US $0.490B 0.00
Tourmaline Bio (TRML) US $0.458B 0.00
Amylyx Pharmaceuticals (AMLX) US $0.458B 0.00
Elite Pharmaceuticals (ELTP) US $0.454B 0.00
Zevra Therapeutics (ZVRA) US $0.418B 0.00
Altimmune (ALT) US $0.398B 0.00
Siga Technologies (SIGA) US $0.388B 6.62
Oruka Therapeutics (ORKA) US $0.378B 0.00
CytoDyn (CYDY) US $0.368B 0.00
Heron Therapeutics (HRTX) US $0.358B 0.00
Rigel Pharmaceuticals (RIGL) US $0.334B 19.92
Aquestive Therapeutics (AQST) US $0.298B 0.00
ProKidney (PROK) US $0.250B 0.00
Avita Medical (RCEL) US $0.247B 0.00
Nature's Sunshine Products (NATR) US $0.227B 26.70
Wellgistics Health (WGRX) US $0.223B 0.00
OmniAb (OABI) US $0.216B 0.00
Esperion Therapeutics (ESPR) US $0.195B 24.60
MediWound (MDWD) IL $0.186B 0.00
Larimar Therapeutics (LRMR) US $0.183B 0.00
Korro Bio (KRRO) US $0.173B 0.00
Inhibikase Therapeutics (IKT) US $0.167B 0.00
Aldeyra Therapeutics (ALDX) US $0.162B 0.00
4D Molecular Therapeutics (FDMT) US $0.159B 0.00
Journey Medical (DERM) US $0.159B 0.00
Lexeo Therapeutics (LXEO) US $0.156B 0.00
Nanobiotix S.A (NBTX) FR $0.156B 0.00
Procaps Group, S.A (PROCF) LU $0.156B 0.00
Aclaris Therapeutics (ACRS) US $0.149B 0.00
Ironwood Pharmaceuticals (IRWD) US $0.148B 45.60
Nektar Therapeutics (NKTR) US $0.145B 0.00
Profound Medical (PROF) CA $0.145B 0.00
Lyell Immunopharma (LYEL) US $0.139B 0.00
Protara Therapeutics (TARA) US $0.133B 0.00
Enanta Pharmaceuticals (ENTA) US $0.129B 0.00
Innate Pharma SA (IPHYF) FR $0.122B 0.00
Tonix Pharmaceuticals Holding (TNXP) US $0.116B 0.00
VAXART, INC (VXRT) US $0.098B 0.00
OptiNose (OPTN) US $0.095B 0.00
Cardiol Therapeutics (CRDL) CA $0.093B 0.00
Corbus Pharmaceuticals Holdings (CRBP) US $0.092B 0.00
Champions Oncology (CSBR) US $0.088B 14.50
Achieve Life Sciences (ACHV) CA $0.085B 0.00
Arch Biopartners (ACHFF) CA $0.083B 0.00
Galectin Therapeutics (GALT) US $0.082B 0.00
ESSA Pharma (EPIX) CA $0.079B 0.00
Cassava Sciences (SAVA) US $0.078B 0.00
Unicycive Therapeutics (UNCY) US $0.078B 0.00
Context Therapeutics (CNTX) US $0.077B 0.00
Telomir Pharmaceuticals (TELO) US $0.075B 0.00
Dominari Holdings (DOMH) US $0.075B 0.00
Nutriband (NTRB) US $0.070B 0.00
Pyxis Oncology (PYXS) US $0.068B 0.00
Cumberland Pharmaceuticals (CPIX) US $0.067B 0.00
Inotiv (NOTV) US $0.067B 0.00
Gain Therapeutics (GANX) US $0.064B 0.00
Assertio Holdings (ASRT) US $0.062B 0.00
Fractyl Health (GUTS) US $0.062B 0.00
Vivani Medical (VANI) US $0.062B 0.00
Allergy Therapeutics (AGYTF) GB $0.059B 0.00
Karyopharm Therapeutics (KPTI) US $0.058B 0.00
Metagenomi (MGX) US $0.056B 0.00
ElectroCore (ECOR) US $0.054B 0.00
Avalo Therapeutics (AVTX) US $0.054B 0.00
PMV Pharmaceuticals (PMVP) US $0.052B 0.00
Century Therapeutics (IPSC) US $0.048B 0.00
Mural Oncology (MURA) IE $0.045B 0.00
Verrica Pharmaceuticals (VRCA) US $0.043B 0.00
Acrivon Therapeutics (ACRV) US $0.042B 0.00
Reviva Pharmaceuticals Holdings (RVPH) US $0.041B 0.00
Prelude Therapeutics (PRLD) US $0.040B 0.00
Rafael Holdings (RFL) US $0.040B 0.00
Iterum Therapeutics (ITRM) IE $0.039B 0.00
SCYNEXIS (SCYX) US $0.038B 0.00
NRx Pharmaceuticals (NRXP) US $0.036B 0.00
Surrozen (SRZN) US $0.034B 0.00
FibroGen (FGEN) US $0.034B 0.00
PolyPid (PYPD) IL $0.029B 0.00
Tempest Therapeutics (TPST) US $0.025B 0.00
CASI Pharmaceuticals (CASI) CN $0.024B 0.00
Enlivex Therapeutics (ENLV) IL $0.022B 0.00
Jupiter Neurosciences (JUNS) US $0.021B 0.00
VYNE Therapeutics (VYNE) US $0.020B 0.00
Mannatech (MTEX) US $0.020B 7.86
Lipocine (LPCN) US $0.019B 0.00
Natural Alternatives (NAII) US $0.019B 0.00
DURECT (DRRX) US $0.018B 0.00
GlycoMimetics (GLYC) US $0.017B 0.00
TherapeuticsMD (TXMD) US $0.016B 0.00
Vivos Therapeutics (VVOS) US $0.016B 0.00
BioVie (BIVI) US $0.016B 0.00
MEI Pharma (MEIP) US $0.014B 0.00
ProPhase Labs (PRPH) US $0.014B 0.00
MARKER THERAPEUTICS, INC (MRKR) US $0.013B 0.00
TransCode Therapeutics (RNAZ) US $0.013B 0.00
Cosmos Health (COSM) US $0.013B 0.00
Scienture Holdings (SCNX) US $0.012B 0.00
Minerva Neurosciences (NERV) US $0.012B 8.79
Relmada Therapeutics (RLMD) US $0.012B 0.00
BioLineRx (BLRX) IL $0.011B 0.00
Plus Therapeutics (PSTV) US $0.011B 0.00
Ernexa Therapeutics (ERNA) US $0.010B 0.00
Kiora Pharmaceuticals (KPRX) US $0.010B 3.16
Biomerica (BMRA) US $0.009B 0.00
Addex Therapeutics (ADXN) CH $0.009B 0.00
Phio Pharmaceuticals (PHIO) US $0.009B 0.00
Talphera (TLPH) US $0.009B 0.00
Carisma Therapeutics (CARM) US $0.008B 0.00
Ainos (AIMD) US $0.008B 0.00
XTL Biopharmaceuticals (XTLB) IL $0.008B 0.00
Mangoceuticals (MGRX) US $0.008B 0.00
Nuvilex (PMCB) US $0.008B 0.00
Jaguar Animal Health (JAGX) US $0.008B 0.00
Indaptus Therapeutics (INDP) US $0.008B 0.00
Traws Pharma (TRAW) US $0.008B 0.00
Lyra Therapeutics (LYRA) US $0.007B 0.00
Citius Pharmaceuticals (CTXR) US $0.007B 0.00
Conduit Pharmaceuticals (CDT) US $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) US $0.006B 0.00
NLS Pharmaceutics (NLSP) CH $0.005B 0.00
Klotho Neurosciences (KLTO) US $0.005B 0.00
Aptorum Group (APM) GB $0.005B 0.00
CERo Therapeutics Holdings (CERO) US $0.005B 0.00
Clearmind Medicine (CMND) CA $0.004B 0.00
Xenetic Biosciences (XBIO) US $0.004B 0.00
XORTX Therapeutics (XRTX) CA $0.004B 0.00
Quoin Pharmaceuticals (QNRX) US $0.004B 0.00
Redhill Biopharma (RDHL) IL $0.004B 0.00
InMed Pharmaceuticals (INM) CA $0.004B 0.00
Alaunos Therapeutics (TCRT) US $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) US $0.004B 0.00
SciSparc (SPRC) IL $0.003B 0.00
Qualigen Therapeutics (QLGN) US $0.003B 0.00
Incannex Healthcare (IXHL) AU $0.002B 0.00
Galmed Pharmaceuticals (GLMD) IL $0.002B 0.00
TNF Pharmaceuticals (TNFA) US $0.002B 0.00
PainReform (PRFX) IL $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) US $0.002B 0.00
China SXT Pharmaceuticals (SXTC) CN $0.002B 0.00
SHINECO (SISI) CN $0.002B 0.00
Salarius Pharmaceuticals (SLRX) US $0.001B 0.00
Heatwurx (PCSA) US $0.001B 0.00
Petros Pharmaceuticals (PTPI) US $0.001B 0.00
Universe Pharmaceuticals INC (UPC) CN $0.000B 0.00
Aditxt (ADTX) US $0.000B 0.00
4D Pharma (LBPS) GB $0.000B 0.00
Patheon (PTHN) NL $0.000B 0.00
RVL Pharmaceuticals (RVLP) US $0.000B 0.00
Silence Therapeutics (SLN) GB $0.000B 0.00